Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 417

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 417
---
 | ​ | ​ | ​ | ​                         | ​ |       — | ​ | ​ | ​ | ​                  | ​ |    -642,900 | ​ | ​ | ​ | ​                          | ​ |    -642,900 | ​ | ​ |
| Balance as of September 30,2024                                     | ​ | ​ | ​                    | ​ | 6,900,000 | ​ | ​ | ​ | ​      | $ | 690 | ​ | ​ | ​ | ​                    | ​ | — | ​ | ​ | ​ | ​      | $ | — | ​ | ​ | ​ | ​                                  | $ | -117,669 | ​ | ​ | ​ | ​                         | $ |  52,287 | ​ | ​ | ​ | ​                  | $ | -16,642,469 | ​ | ​ | ​ | ​                          | $ | -16,707,161 | ​ | ​ |

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023

| ​                                                             
 ​                                                             | ​ 
 ​ | ​ 
 ​ | Class A Common Stock 
 Shares               |   |           |   | ​ | ​ | Amount |   |     |   | ​ 
 ​ | ​ 
 ​ | Class B Common Stock 
 Shares               |   |            |   | ​ | ​ | Amount |   |      |   | ​ 
 ​ | ​ | AdditionalPaid-in Capital |   |         |   | ​ | ​ | AccumulatedDeficit |   |             |   | ​ | ​ | Total Stockholders’Deficit |   |             |   | ​ |
|:--------------------------------------------------------------|:--|:--|:---------------------|:--|----------:|:--|:--|:--|:-------|:--|----:|:--|:--|:--|:---------------------|:--|-----------:|:--|:--|:--|:-------|:--|-----:|:--|:--|:--|:--------------------------|:--|--------:|:--|:--|:--|:-------------------|:--|------------:|:--|:--|:--|:---------------------------|:--|------------:|:--|:--|
| Balance as of January 1, 2023                                 | ​ | ​ | ​                    | ​ |         — | ​ | ​ | ​ | ​